- Home
- CERS vs REFI Comparison
CERS vs REFI Comparison
Compare CERS & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- REFI
- Stock Information
- Founded
- CERS 1991
- REFI 2021
- Country
- CERS United States
- REFI United States
- Employees
- CERS N/A
- REFI N/A
- Industry
- CERS EDP Services
- REFI Real Estate Investment Trusts
- Sector
- CERS Technology
- REFI Real Estate
- Exchange
- CERS Nasdaq
- REFI Nasdaq
- Market Cap
- CERS 347.3M
- REFI 291.9M
- IPO Year
- CERS 1997
- REFI 2021
- Fundamental
- Price
- CERS $1.29
- REFI $14.97
- Analyst Decision
- CERS Strong Buy
- REFI Strong Buy
- Analyst Count
- CERS 2
- REFI 3
- Target Price
- CERS $3.50
- REFI $20.00
- AVG Volume (30 Days)
- CERS 1.0M
- REFI 101.1K
- Earning Date
- CERS 05-01-2025
- REFI 05-07-2025
- Dividend Yield
- CERS N/A
- REFI 13.76%
- EPS Growth
- CERS N/A
- REFI N/A
- EPS
- CERS N/A
- REFI 1.88
- Revenue
- CERS $185,144,000.00
- REFI $56,790,054.00
- Revenue This Year
- CERS $25.57
- REFI $17.87
- Revenue Next Year
- CERS $10.54
- REFI N/A
- P/E Ratio
- CERS N/A
- REFI $7.96
- Revenue Growth
- CERS 13.06
- REFI 4.68
- 52 Week Low
- CERS $1.12
- REFI $12.76
- 52 Week High
- CERS $2.54
- REFI $16.47
- Technical
- Relative Strength Index (RSI)
- CERS 45.00
- REFI 62.01
- Support Level
- CERS $1.22
- REFI $14.50
- Resistance Level
- CERS $1.38
- REFI $14.81
- Average True Range (ATR)
- CERS 0.07
- REFI 0.27
- MACD
- CERS 0.00
- REFI 0.12
- Stochastic Oscillator
- CERS 26.92
- REFI 90.91
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.